Profile | GDS5420 / 211475_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1158.86 | 81 |
GSM1296119 | B_lesional_pre-dose | 1061.81 | 80 |
GSM1296076 | C_lesional_pre-dose | 972.66 | 79 |
GSM1296092 | D_lesional_pre-dose | 1289.09 | 82 |
GSM1296103 | E_lesional_pre-dose | 1391.83 | 84 |
GSM1296078 | F_lesional_pre-dose | 1212.41 | 82 |
GSM1296107 | G_lesional_pre-dose | 1321.62 | 84 |
GSM1296109 | H_lesional_pre-dose | 1375.65 | 84 |
GSM1296080 | I_lesional_pre-dose | 750.62 | 74 |
GSM1296090 | J_lesional_pre-dose | 1078.27 | 80 |
GSM1296074 | K_lesional_pre-dose | 1005.61 | 79 |
GSM1296111 | L_lesional_pre-dose | 1319.17 | 84 |
GSM1296099 | M_lesional_pre-dose | 1497.7 | 85 |
GSM1296086 | O_lesional_pre-dose | 1265.82 | 82 |
GSM1296117 | P_lesional_pre-dose | 1022.65 | 80 |
GSM1296113 | Q_lesional_pre-dose | 1030.89 | 80 |
GSM1296096 | R_lesional_pre-dose | 1721.49 | 87 |
GSM1296105 | S_lesional_pre-dose | 904.76 | 77 |
GSM1296098 | T_lesional_pre-dose | 1062.51 | 80 |
GSM1296101 | U_lesional_pre-dose | 1741.73 | 87 |
GSM1296121 | V_lesional_pre-dose | 1120.84 | 81 |
GSM1296088 | W_lesional_pre-dose | 1074.27 | 80 |
GSM1296082 | X_lesional_pre-dose | 1191.24 | 81 |
GSM1296115 | Y_lesional_pre-dose | 1432.9 | 85 |
GSM1296084 | Z_lesional_pre-dose | 1163.35 | 81 |
GSM1296072 | B_lesional_day8 | 1130.85 | 81 |
GSM1296069 | L_lesional_day8 | 1168.15 | 82 |
GSM1296071 | P_lesional_day8 | 936.1 | 78 |
GSM1296070 | Y_lesional_day8 | 1378.63 | 85 |
GSM1296073 | V_lesional_day8 | 1096.83 | 81 |
GSM1296034 | A_lesional_day15 | 766.36 | 74 |
GSM1296041 | G_lesional_day15 | 1305.06 | 83 |
GSM1296035 | R_lesional_day15 | 1823.26 | 88 |
GSM1296038 | U_lesional_day15 | 1299.57 | 83 |
GSM1296047 | B_lesional_day15 | 1098.54 | 81 |
GSM1296039 | E_lesional_day15 | 1541.07 | 85 |
GSM1296042 | H_lesional_day15 | 1225.03 | 83 |
GSM1296043 | L_lesional_day15 | 1276.11 | 83 |
GSM1296037 | M_lesional_day15 | 1465.4 | 85 |
GSM1296046 | P_lesional_day15 | 993.48 | 79 |
GSM1296044 | Q_lesional_day15 | 1150.47 | 82 |
GSM1296045 | Y_lesional_day15 | 1185.58 | 82 |
GSM1296025 | C_lesional_day15 | 497.75 | 68 |
GSM1296033 | D_lesional_day15 | 1248.96 | 82 |
GSM1296027 | I_lesional_day15 | 921.75 | 77 |
GSM1296032 | J_lesional_day15 | 1135.27 | 81 |
GSM1296024 | K_lesional_day15 | 668.07 | 72 |
GSM1296031 | W_lesional_day15 | 713.37 | 73 |
GSM1296028 | X_lesional_day15 | 932.56 | 78 |
GSM1296029 | Z_lesional_day15 | 927.85 | 78 |
GSM1296026 | F_lesional_day15 | 980.89 | 79 |
GSM1296030 | O_lesional_day15 | 1025.69 | 79 |
GSM1296040 | S_lesional_day15 | 1499.52 | 85 |
GSM1296036 | T_lesional_day15 | 565.73 | 69 |
GSM1296048 | V_lesional_day15 | 1175.53 | 82 |
GSM1296059 | A_lesional_day43 | 1903.93 | 88 |
GSM1296066 | G_lesional_day43 | 1338.7 | 84 |
GSM1296060 | R_lesional_day43 | 1751.76 | 87 |
GSM1296063 | U_lesional_day43 | 1371.6 | 84 |
GSM1296064 | E_lesional_day43 | 1761.85 | 87 |
GSM1296067 | H_lesional_day43 | 1017.54 | 80 |
GSM1296062 | M_lesional_day43 | 1066.13 | 80 |
GSM1296068 | Q_lesional_day43 | 1145.69 | 82 |
GSM1296050 | C_lesional_day43 | 537.53 | 69 |
GSM1296057 | D_lesional_day43 | 1903.06 | 89 |
GSM1296052 | I_lesional_day43 | 809.15 | 75 |
GSM1296054 | J_lesional_day43 | 812.71 | 76 |
GSM1296049 | K_lesional_day43 | 468.84 | 67 |
GSM1296055 | W_lesional_day43 | 1184.61 | 82 |
GSM1296053 | X_lesional_day43 | 707.48 | 73 |
GSM1296058 | Z_lesional_day43 | 1798.74 | 88 |
GSM1296051 | F_lesional_day43 | 883.37 | 77 |
GSM1296056 | O_lesional_day43 | 1872.47 | 88 |
GSM1296065 | S_lesional_day43 | 1399.67 | 84 |
GSM1296061 | T_lesional_day43 | 779.01 | 75 |
GSM1296095 | A_non-lesional_pre-dose | 2452.79 | 91 |
GSM1296120 | B_non-lesional_pre-dose | 1031.93 | 80 |
GSM1296077 | C_non-lesional_pre-dose | 671.24 | 73 |
GSM1296093 | D_non-lesional_pre-dose | 925.21 | 78 |
GSM1296104 | E_non-lesional_pre-dose | 1860.96 | 88 |
GSM1296079 | F_non-lesional_pre-dose | 618.09 | 71 |
GSM1296108 | G_non-lesional_pre-dose | 1235.06 | 83 |
GSM1296110 | H_non-lesional_pre-dose | 1086.54 | 81 |
GSM1296081 | I_non-lesional_pre-dose | 609.05 | 71 |
GSM1296091 | J_non-lesional_pre-dose | 1165.89 | 81 |
GSM1296075 | K_non-lesional_pre-dose | 875.43 | 77 |
GSM1296112 | L_non-lesional_pre-dose | 1198.33 | 83 |
GSM1296100 | M_non-lesional_pre-dose | 1937.18 | 89 |
GSM1296087 | O_non-lesional_pre-dose | 1125.38 | 81 |
GSM1296118 | P_non-lesional_pre-dose | 1109.63 | 81 |
GSM1296114 | Q_non-lesional_pre-dose | 1193.75 | 82 |
GSM1296097 | R_non-lesional_pre-dose | 2049.18 | 89 |
GSM1296106 | S_non-lesional_pre-dose | 1264.89 | 83 |
GSM1296102 | U_non-lesional_pre-dose | 932.71 | 78 |
GSM1296122 | V_non-lesional_pre-dose | 742.8 | 74 |
GSM1296089 | W_non-lesional_pre-dose | 869.78 | 77 |
GSM1296083 | X_non-lesional_pre-dose | 891.15 | 77 |
GSM1296116 | Y_non-lesional_pre-dose | 1128 | 82 |
GSM1296085 | Z_non-lesional_pre-dose | 849.28 | 76 |